Skip to content

8-KAccepted Sep 29, 5:25 PM ET

Aterian, Inc.: Major Share Sale, Board Change and CEO Retention Bonus

ATERAterian, Inc.

Accepted (ET)

5:25 PM

Sep 29, 2026

Filed

Sep 29, 2026

Documents

15

Size

213.5 KB

Summary

Aterian, Inc.: Major Share Sale, Board Change and CEO Retention Bonus

Updated

What Happened

  • Aterian, Inc. announced that David E. Lazar sold certain converted preferred-share interests on September 25, 2026 under a September 2026 SPA for an aggregate $12,000,000. Immediately prior to the sale the Series AA and Series AAA preferred stock were converted into an aggregate of 241,861,970 shares of common stock. After the transaction Mr. Lazar holds approximately 3.1% of outstanding common stock and may no longer be deemed to control the company; no purchaser acquired more than 9.99% on a fully diluted basis.
  • The company also reported board changes effective September 25, 2026: Avraham Ben‑Tzvi resigned (not due to any disagreement with the company) and William H. Crampton was appointed to the Board and to the Audit and Compensation Committees. The Compensation Committee granted Mr. Crampton 301,205 restricted shares (vesting over three years) and the company authorized its standard indemnification agreement.
  • Separately, the Compensation Committee approved a $150,000 retention bonus for CEO (and Interim CFO) David E. Lazar: $75,000 payable September 30, 2026 and $75,000 payable within five business days after Aterian files its Form 10‑Q for the quarter ended September 30, 2026 (with limited payment protections if terminated without cause or by reason of death/disability). The company also issued a CVR cash payment notice of approximately $0.9936 per contingent value right to be distributed on or about October 2, 2026.

Key Details

  • $12,000,000 aggregate purchase price for the sold converted preferred interests (September 25, 2026 SPA).
  • 241,861,970 shares of common stock resulted from conversion of Series AA and Series AAA preferred stock immediately prior to the sale.
  • Post‑transaction ownership: David Lazar ≈ 3.1% of common stock; no Purchaser > 9.99% (fully diluted).
  • Board changes effective Sept 25, 2026: Avraham Ben‑Tzvi resignation; William H. Crampton appointed and granted 301,205 restricted shares (vesting over 3 years). CVR cash payment ≈ $0.9936 per CVR, distribution ~Oct 2, 2026.

Why It Matters

  • The sale and conversion significantly altered ownership stakes and may change who is viewed as controlling the company; that can affect governance, voting outcomes and strategic direction.
  • The board appointment and director equity grant are material governance updates; new committee membership (Audit/Compensation) could influence oversight and executive pay.
  • The CEO retention bonus confirms management continuity through the upcoming 10‑Q filing date. The announced CVR cash distribution returns near‑term cash to holders of the contingent value rights.

AI-written summary · check the filing